Company intelligence / Profile preview

SQuip

Santa Rosa, California, United States
Ownership
Private
Development stage
Other
01

Overview

SQuip is a U.S. consumer health company focused on drug-free nasal, ear-care, and respiratory-support products for adults, children, and infants. Its portfolio includes nasal irrigation systems, nasal and oral aspirators, earwax removal products, saline-based care products, and related wellness devices marketed under brands such as Nasaline, NasaKleen, Baby NasaKleen, Kyrosol, Andas, Salitair, and Snooze. The business originated from CAMEXCO, began commercializing Nasaline in North America in 2002, and was renamed SQUIP in 2007. SQuip and ENTpro were purchased by the owners of NeilMed Pharmaceuticals in 2018, and Squip, Inc. became part of NeilMed Pharmaceuticals on July 1, 2020. Today the brand operates as part of NeilMed's OTC nasal-care portfolio and sells established commercial products rather than a traditional drug-development pipeline.

Therapeutic areas
PulmonologyOther
Modalities
DeviceNon-pharmacological therapy
Industry
Therapeutic Medical Devices
02

Partnerships

ENTpro

Beyond the preview

Go deeper on SQuip.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SQuip.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call